Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
SPDR S&P Pharmaceuticals ETF
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.
IPO Date: July 1, 2006
Sector: Healthcare
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.43 | 0.88%
Avg Daily Range (30 D): $0.42 | 1.06%
Avg Daily Range (90 D): $0.48 | 1.17%
Institutional Daily Volume
Avg Daily Volume: .07M
Avg Daily Volume (30 D): .04M
Avg Daily Volume (90 D): .04M
Trade Size
Avg Trade Size (Sh.): 231
Avg Trade Size (Sh.) (30 D): 191
Avg Trade Size (Sh.) (90 D): 187
Institutional Trades
Total Inst.Trades: 1,170
Avg Inst. Trade: $3.08M
Avg Inst. Trade (30 D): $.91M
Avg Inst. Trade (90 D): $3.89M
Avg Inst. Trade Volume: .08M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.6M
Avg Closing Trade (30 D): $.52M
Avg Closing Trade (90 D): $.52M
Avg Closing Volume: 37.85K
       
News
May 27, 2024 @ 5:45 AM
Unloved Gilead Due For Reversal On Flight-To-Safet...
Source: Paul Franke
May 16, 2024 @ 10:20 AM
Should You Invest in the SPDR S&P Pharmaceuticals ...
Source: Zacks Equity Research
May 14, 2024 @ 12:00 PM
5 Beaten-Down Top-Ranked ETFs to Buy for a Turnaro...
Source: Sanghamitra Saha
May 7, 2024 @ 3:30 PM
A Look at Pharma ETFs Post Q1 Earnings
Source: Sweta Killa
Feb 15, 2024 @ 11:20 AM
Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF...
Source: Zacks Equity Research
Splits
Sep 11, 2015:   2:1